Kim, Jong-Ho
Kim, Jin-Sun
Jeon, Yeong-Gwan
Bae, Jangho
Shin, Kiyoung
Hwang, Byeongmun
Funding for this research was provided by:
Daiichi-Sankyo Korea (2021-09-014, 2021-09-014, 2021-09-014, 2021-09-014, 2021-09-014, 2021-09-014)
Article History
Received: 16 June 2023
Accepted: 31 October 2023
First Online: 7 November 2023
Declarations
:
: The study design was approved by the Institutional Review Boards of the Hallym University Chuncheon Sacred Heart Hospital (IRB no. 2021-11-002), Wonju Severance Christian Hospital (IRB no. CR121091), Gangneung Asan Hospital (IRB no. GNAH 2022-01-002), and Kangwon National University Hospital (IRB no. 2021-09-014). This trial was registered at the Clinical Research Information Service (criskorea@korea.kr, KCT0006749) and conducted in accordance with the Declaration of Helsinki. The study protocol followed the CONSORT guidelines. Written informed consent was obtained from each participant before the administration of any study drug.
: Not applicable.
: The authors declare that there are no conflicts of interest regarding the publication of this paper.